Biotechnology Division of Olympus, Inc. Olympus has long been involved in R&D and business activities relating to various aspects of regenerative medicine. In December 2010, Olympus Corporation announced the establishment of Olympus Biotech Corporation, and in February 2011, completed its acquisition of Osteogenic Protein-1 (OP-1™) bone-related assets from Stryker Biotech (a division of Stryker Corporation).
View Top Employees from Olympus Biotech International| Website | https://www.olympusbiotech.com |
| Revenue | $15 million |
| Employees | 30 (30 on RocketReach) |
| Founded | 2011 |
| Phone | (508) 416-5300 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+25 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Olympus Biotech International employee's phone or email?
Olympus Biotech International Questions
The Olympus Biotech International annual revenue was $15 million in 2023.
Jeffrey Damren is the Director of Manufacturing of Olympus Biotech International.
30 people are employed at Olympus Biotech International.
The NAICS codes for Olympus Biotech International are [3254, 32, 325].
The SIC codes for Olympus Biotech International are [28, 283].
Top Olympus Biotech International Employees
-
View
Sarah Thompson
Business Analyst and IS Compliance at Olympus Biotech International
Hopkinton, MA, US11 -
5+5+
-
23
-
11
